The human trial of the first stage of covaxine is almost complete. In Rohtak PGI, samples of all eighty volunteers will be taken by 28 August, which will be sent for the test. These blood samples will show the amount of antibodies made in the body of the volunteer and only after that the second stage will start.

Human testing of covaccine is underway at 375 volunteers in 12 medical institutes of the country, of which more than 20% is registered in Rohtak PGI alone. Second dose of all valentines and score covaxin has also been given here, now blood samples of all volunteers are being taken.

OP Kalra, VC of Health University, said that the first stage of the vaccine in PGI Rohtak has almost been completed. Antibodies will be reported in the first week of September on how effective the drug has been and how much effect the Volunteers have been given in the first 3mg dose and the second dose of 6mg given 14 days later. is. The second phase will start only after their results and in that it will be decided whether to give a dose of 3 mg or 6 mg kDa to second phase volunteers. Kalra told that we had three main objectives in the first phase. In which the first vaccine is so safe. How effective the dose is and how many antibodies are made in 14 days and 28 days, so that its effect can be detected. Now data is being collected from all over the country and we expect to get results in the first week of September.

Also Read:

Goa: Assembly speaker will not be discharged from hospital for a few days

Retail vegetable prices spike in Delhi and NCR

Palwal's recovery rate of coronavirus is 92.25 %

Lawrence Bishnoi who threatened to kill Salman Khan fears encounter